• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内脏脂肪去除和扩张后的代谢改变:超越解剖位置。

Metabolic alterations following visceral fat removal and expansion: Beyond anatomic location.

作者信息

Foster Michelle T, Pagliassotti Michael J

机构信息

Department of Food Science and Human Nutrition; Colorado State University; Fort Collins, CO USA.

出版信息

Adipocyte. 2012 Oct 1;1(4):192-199. doi: 10.4161/adip.21756.

DOI:10.4161/adip.21756
PMID:23700533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3609102/
Abstract

Increased visceral adiposity is a risk factor for metabolic disorders such as dyslipidemia, hypertension, insulin resistance and type 2 diabetes, whereas peripheral (subcutaneous) obesity is not. Though the specific mechanisms which contribute to these adipose depot differences are unknown, visceral fat accumulation is proposed to result in metabolic dysregulation because of increased effluent, e.g., fatty acids and/or adipokines/cytokines, to the liver via the hepatic portal vein. Pathological significance of visceral fat accumulation is also attributed to adipose depot/adipocyte-specific characteristics, specifically differences in structural, physiologic and metabolic characteristics compared with subcutaneous fat. Fat manipulations, such as removal or transplantation, have been utilized to identify location dependent or independent factors that play a role in metabolic dysregulation. Obesity-induced alterations in adipose tissue function/intrinsic characteristics, but not mass, appear to be responsible for obesity-induced metabolic dysregulation, thus "quality" is more important than "quantity." This review summarizes the implications of obesity-induced metabolic dysfunction as it relates to anatomic site and inherent adipocyte characteristics.

摘要

内脏脂肪增多是血脂异常、高血压、胰岛素抵抗和2型糖尿病等代谢紊乱的危险因素,而外周(皮下)肥胖则不是。尽管导致这些脂肪储存差异的具体机制尚不清楚,但有人提出,内脏脂肪堆积会导致代谢失调,因为通过肝门静脉进入肝脏的流出物(如脂肪酸和/或脂肪因子/细胞因子)增加。内脏脂肪堆积的病理意义还归因于脂肪储存/脂肪细胞的特异性特征,特别是与皮下脂肪相比,在结构、生理和代谢特征上的差异。脂肪操作,如切除或移植,已被用于确定在代谢失调中起作用的位置依赖性或独立性因素。肥胖引起的脂肪组织功能/内在特征的改变,而非脂肪量的改变,似乎是肥胖引起代谢失调的原因,因此“质量”比“数量”更重要。本综述总结了肥胖引起的代谢功能障碍与解剖部位和固有脂肪细胞特征的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/3609102/7a2a8cecc949/adip-1-192-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/3609102/52e7023d3bb4/adip-1-192-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/3609102/7a2a8cecc949/adip-1-192-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/3609102/52e7023d3bb4/adip-1-192-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/3609102/7a2a8cecc949/adip-1-192-g2.jpg

相似文献

1
Metabolic alterations following visceral fat removal and expansion: Beyond anatomic location.内脏脂肪去除和扩张后的代谢改变:超越解剖位置。
Adipocyte. 2012 Oct 1;1(4):192-199. doi: 10.4161/adip.21756.
2
Subcutaneous Adipose Tissue Transplantation in Diet-Induced Obese Mice Attenuates Metabolic Dysregulation While Removal Exacerbates It.饮食诱导肥胖小鼠皮下脂肪组织移植可减轻代谢失调,而切除皮下脂肪组织则会加剧代谢失调。
Physiol Rep. 2013 Aug;1(2). doi: 10.1002/phy2.15.
3
The role of visceral and subcutaneous adipose tissue fatty acid composition in liver pathophysiology associated with NAFLD.内脏和皮下脂肪组织脂肪酸组成在与非酒精性脂肪性肝病相关的肝脏病理生理学中的作用。
Adipocyte. 2015 Jan 14;4(2):101-12. doi: 10.4161/21623945.2014.978662. eCollection 2015 Apr-Jun.
4
Central role of the adipocyte in the metabolic syndrome.脂肪细胞在代谢综合征中的核心作用。
J Investig Med. 2001 Jan;49(1):119-26. doi: 10.2310/6650.2001.34108.
5
Detrimental and protective fat: body fat distribution and its relation to metabolic disease.有害脂肪与保护性脂肪:体脂分布及其与代谢性疾病的关系
Horm Mol Biol Clin Investig. 2014 Jan;17(1):13-27. doi: 10.1515/hmbci-2014-0009.
6
Visceral fat and insulin resistance--causative or correlative?内脏脂肪与胰岛素抵抗——因果关系还是相关性?
Br J Nutr. 2000 Mar;83 Suppl 1:S71-7. doi: 10.1017/s0007114500000982.
7
Obesity associated disease risk: the role of inherent differences and location of adipose depots.肥胖相关疾病风险:脂肪储存部位固有差异及位置的作用
Horm Mol Biol Clin Investig. 2018 Mar 16;33(2):/j/hmbci.2018.33.issue-2/hmbci-2018-0012/hmbci-2018-0012.xml. doi: 10.1515/hmbci-2018-0012.
8
Control of adipocyte differentiation in different fat depots; implications for pathophysiology or therapy.不同脂肪组织中脂肪细胞分化的控制;对病理生理学或治疗的影响。
Front Endocrinol (Lausanne). 2015 Jan 30;6:1. doi: 10.3389/fendo.2015.00001. eCollection 2015.
9
Different adipose tissue depots: Metabolic implications and effects of surgical removal.不同的脂肪组织储存库:代谢影响及手术切除的效果
Endocrinol Nutr. 2015 Nov;62(9):458-64. doi: 10.1016/j.endonu.2015.05.010. Epub 2015 Aug 20.
10
Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity.血管紧张素受体结合蛋白 ATRAP/Agtrap 可抑制内脏肥胖引起的代谢功能障碍。
J Am Heart Assoc. 2013 Jul 31;2(4):e000312. doi: 10.1161/JAHA.113.000312.

引用本文的文献

1
Effects of Endoscopic Sleeve Gastroplasty on Body Composition and Metabolism: An InBody Analysis.内镜下袖状胃成形术对身体成分和代谢的影响:一项人体成分分析
Obes Surg. 2025 Sep 8. doi: 10.1007/s11695-025-08194-9.
2
Obesity-Related Differences in Amygdala and Hippocampus Volume and Metabolism in Major Depressive Disorder: Implications for Antidepressant Treatment.重度抑郁症中杏仁核和海马体体积及代谢与肥胖相关的差异:对抗抑郁治疗的启示
Res Sq. 2025 May 8:rs.3.rs-6257703. doi: 10.21203/rs.3.rs-6257703/v1.
3
Perspective from NHANES data: synergistic effects of visceral adiposity index and lipid accumulation products on diabetes risk.

本文引用的文献

1
Functional differences in visceral and subcutaneous fat pads originate from differences in the adipose stem cell.内脏和皮下脂肪垫的功能差异源于脂肪干细胞的差异。
PLoS One. 2012;7(5):e36569. doi: 10.1371/journal.pone.0036569. Epub 2012 May 4.
2
Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease.肥胖、内脏脂肪与非酒精性脂肪性肝病:探究脂肪因子在非酒精性脂肪性肝病进展中的作用
ISRN Gastroenterol. 2011;2011:592404. doi: 10.5402/2011/592404. Epub 2011 Aug 28.
3
Metabolic effects of an entero-omentectomy in mildly obese type 2 diabetes mellitus patients after three years.
基于美国国家健康与营养检查调查(NHANES)数据的视角:内脏脂肪指数与脂质蓄积产物对糖尿病风险的协同作用
Sci Rep. 2025 Jan 2;15(1):258. doi: 10.1038/s41598-024-84034-7.
4
Exploring the heterogeneity of hepatic and pancreatic fat deposition in obesity: implications for metabolic health.探讨肥胖症中肝性和胰性脂肪沉积的异质性:对代谢健康的影响。
Front Endocrinol (Lausanne). 2024 Oct 8;15:1447750. doi: 10.3389/fendo.2024.1447750. eCollection 2024.
5
Differences in Lipid Metabolism between the Perirenal Adipose Tissue of Chinese Simmental Cattle and Angus Cattle () Based on Metabolomics Analysis.基于代谢组学分析的中国西门塔尔牛和安格斯牛肾周脂肪组织脂质代谢差异()
Animals (Basel). 2024 Aug 31;14(17):2536. doi: 10.3390/ani14172536.
6
Perirenal fat thickness as a superior obesity-related marker of subclinical carotid atherosclerosis in type 2 diabetes mellitus.肾周脂肪厚度是 2 型糖尿病患者亚临床颈动脉粥样硬化的一种较好的肥胖相关标志物。
Front Endocrinol (Lausanne). 2023 Oct 27;14:1276789. doi: 10.3389/fendo.2023.1276789. eCollection 2023.
7
Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment.肥胖的临床分类及其对代谢功能障碍相关脂肪性肝病和治疗的影响
Diabetes Metab Syndr Obes. 2023 Oct 25;16:3303-3329. doi: 10.2147/DMSO.S431251. eCollection 2023.
8
GABA Prevents Age-Related Sarcopenic Obesity in Mice with High-Fat-Diet-Induced Obesity.GABA 可预防高脂肪饮食诱导肥胖的小鼠的与年龄相关的肌少症性肥胖。
Cells. 2023 Aug 25;12(17):2146. doi: 10.3390/cells12172146.
9
Perirenal Fat Thickness is Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes Mellitus.肾周脂肪厚度与2型糖尿病患者代谢功能障碍相关脂肪性肝病有关。
Diabetes Metab Syndr Obes. 2023 Jun 28;16:1953-1965. doi: 10.2147/DMSO.S415477. eCollection 2023.
10
Differential Metabolism of Glycerol Based on Oral versus Intravenous Administration in Humans.基于口服与静脉给药在人体中甘油的差异代谢
Metabolites. 2022 Sep 22;12(10):890. doi: 10.3390/metabo12100890.
肠-网膜切除术对三年后轻度肥胖 2 型糖尿病患者代谢的影响。
Clinics (Sao Paulo). 2011;66(7):1227-33. doi: 10.1590/s1807-59322011000700018.
4
Transplantation of non-visceral fat to the visceral cavity improves glucose tolerance in mice: investigation of hepatic lipids and insulin sensitivity.将非内脏脂肪移植到内脏腔可改善小鼠的葡萄糖耐量:对肝脏脂质和胰岛素敏感性的研究。
Diabetologia. 2011 Nov;54(11):2890-9. doi: 10.1007/s00125-011-2259-5. Epub 2011 Jul 30.
5
Removal of intra-abdominal visceral adipose tissue improves glucose tolerance in rats: role of hepatic triglyceride storage.去除腹腔内内脏脂肪组织可改善大鼠的葡萄糖耐量:肝甘油三酯储存的作用。
Physiol Behav. 2011 Oct 24;104(5):845-54. doi: 10.1016/j.physbeh.2011.04.064. Epub 2011 Jun 12.
6
Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects.门静脉和全身脂联素浓度与极度肥胖患者的肝葡萄糖和脂蛋白动力学密切相关。
Metabolism. 2011 Nov;60(11):1641-8. doi: 10.1016/j.metabol.2011.03.019. Epub 2011 May 31.
7
Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women.内脏脂肪细胞肥大与血脂异常有关,与女性的身体成分和脂肪分布无关。
Diabetes. 2011 May;60(5):1504-11. doi: 10.2337/db10-1039. Epub 2011 Mar 18.
8
Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity.人体肥胖中局部脂肪库的差异及皮下脂肪组织血管生成不足。
Circulation. 2011 Jan 18;123(2):186-94. doi: 10.1161/CIRCULATIONAHA.110.970145. Epub 2011 Jan 3.
9
Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans.AMP 激活的蛋白激酶活性降低与内脏脂肪组织炎症增加以及病态肥胖人群全身胰岛素抵抗有关。
Biochem Biophys Res Commun. 2011 Jan 7;404(1):382-7. doi: 10.1016/j.bbrc.2010.11.127. Epub 2010 Dec 3.
10
The portal theory supported by venous drainage-selective fat transplantation.静脉引流选择性脂肪移植所支持的门控理论。
Diabetes. 2011 Jan;60(1):56-63. doi: 10.2337/db10-0697. Epub 2010 Oct 18.